Skip to main content

ADVERTISEMENT

Orbital atherectomy

ORIGINAL CONTRIBUTION
10/24/2019

Michael S. Lee, MD¹;  Evan Shlofmitz, DO²;  Seung-Woon Rha, MD, PhD³;  Richard Shlofmitz, MD4

Michael S. Lee, MD¹;  Evan Shlofmitz,...
OA is an effective tool to modify calcified plaque prior to stenting. However, advancement of the OA crown may be technically challenging due to complex coronary anatomy. We report our initial experience with GlideAssist to facilitate...
OA is an effective tool to modify calcified plaque prior to stenting. However, advancement of the OA crown may be technically challenging due to complex coronary anatomy. We report our initial experience with GlideAssist to facilitate...
OA is an effective tool to...
10/24/2019
Journal of Invasive Cardiology
Case Report
09/05/2019

Abdul Bahro1, MD, FACC, FSCAI, Connie Williams2, AGACNP-BC, Zsuzsanna Igyarto3, PhD, Brad J. Martinsen4, PhD

Abdul Bahro1, MD, FACC, FSCAI, Connie...
In this report, we present the case of an African-American hemodialysis patient with CHI due to a calcified radial artery who was treated with orbital atherectomy and balloon angioplasty, and underwent follow-up at six weeks post procedure.
In this report, we present the case of an African-American hemodialysis patient with CHI due to a calcified radial artery who was treated with orbital atherectomy and balloon angioplasty, and underwent follow-up at six weeks post procedure.
In this report, we present the...
09/05/2019
Cath Lab Digest
Original Contribution
07/30/2018

Michael S. Lee, MD1;  Evan Shlofmitz, DO2;  Richard Shlofmitz, MD3

Michael S. Lee, MD1;  Evan Shlofmitz,...
We evaluated the outcomes of plaque modification with orbital atherectomy followed by PCI with small-diameter stents for severely calcified coronary arteries.
We evaluated the outcomes of plaque modification with orbital atherectomy followed by PCI with small-diameter stents for severely calcified coronary arteries.
We evaluated the outcomes of...
07/30/2018
Journal of Invasive Cardiology
Original Contribution
03/30/2018

Michael S. Lee, MD¬π;  Evan Shlofmitz, DO¬≤;  Alec Goldberg, BS¬≥;  Richard Shlofmitz, MD¬≥

Michael S. Lee, MD¬π;  Evan Shlofmitz...
We report the 1-year outcomes of real-world patients with severely calcified coronary arteries who underwent orbital atherectomy.
We report the 1-year outcomes of real-world patients with severely calcified coronary arteries who underwent orbital atherectomy.
We report the 1-year outcomes of...
03/30/2018
Journal of Invasive Cardiology
Original Contribution
01/29/2018

Michael S. Lee, MD1;  Evan Shlofmitz, DO2;  Jeremy Kong, MD1;  Gentian Lluri, MD, PhD1;  Pratyaksh K. Srivastava, MD¬π;  Richard Shlofmitz, MD3

Michael S. Lee, MD1;  Evan Shlofmitz,...
We assessed the impact of intravascular ultrasound/optical coherence tomography on outcomes of patients who underwent orbital atherectomy.
We assessed the impact of intravascular ultrasound/optical coherence tomography on outcomes of patients who underwent orbital atherectomy.
We assessed the impact of...
01/29/2018
Journal of Invasive Cardiology
Original Contribution
10/23/2017

Michael S. Lee, MD1;  Evan Shlofmitz, DO2;  Arash Nayeri, MD1;  John Hollowed, MD1;  Jeremy Kong, MD1;  Richard A. Shlofmitz, MD3

Michael S. Lee, MD1;  Evan Shlofmitz,...
Orbital atherectomy modifies calcified plaque, thereby facilitating stent delivery and stent expansion. The ideal antithrombotic agent during orbital atherectomy is unknown. We compared the angiographic and clinical outcomes of heparin and...
Orbital atherectomy modifies calcified plaque, thereby facilitating stent delivery and stent expansion. The ideal antithrombotic agent during orbital atherectomy is unknown. We compared the angiographic and clinical outcomes of heparin and...
Orbital atherectomy modifies...
10/23/2017
Journal of Invasive Cardiology
Original Contribution
02/28/2017

Michael S. Lee, MD1;  Heajung Nguyen, MD1;  Daniel Philipson, MD1;  Richard A. Shlofmitz, MD2

Michael S. Lee, MD1;  Heajung Nguyen,...
We assessed the feasibility and safety of the “single-operator” technique in which the operator autonomously advanced the orbital atherectomy device while maintaining wire position.
We assessed the feasibility and safety of the “single-operator” technique in which the operator autonomously advanced the orbital atherectomy device while maintaining wire position.
We assessed the feasibility and...
02/28/2017
Journal of Invasive Cardiology
Original Contribution
01/31/2017

Michael S. Lee, MD¬π;  Heajung Nguyen, MD¬π;  Richard Shlofmitz, MD¬≤

Michael S. Lee, MD¬π;  Heajung Nguyen...
We analyzed the incidence of bradycardia and the safety of patients with severely calcified coronary lesions who underwent orbital atherectomy without the insertion of a temporary pacemaker.
We analyzed the incidence of bradycardia and the safety of patients with severely calcified coronary lesions who underwent orbital atherectomy without the insertion of a temporary pacemaker.
We analyzed the incidence of...
01/31/2017
Journal of Invasive Cardiology
Ask the Expert
10/07/2016

Arthur C. Lee, MD, FACC, FSCAI, Director of Peripheral Intervention, Cardiac and Vascular Institute; North Florida Regional Medical Center, Gainesville, Florida

 

Arthur C. Lee, MD, FACC, FSCAI, Direc...
This case highlights the fact that the lack of utilizing vessel preparation appropriately can result in lower procedural success rates, higher complication rates, higher contrast and radiation doses, and increased cost.
This case highlights the fact that the lack of utilizing vessel preparation appropriately can result in lower procedural success rates, higher complication rates, higher contrast and radiation doses, and increased cost.
This case highlights the fact...
10/07/2016
Cath Lab Digest
01/29/2013

Prakash Makam, MD

Prakash Makam, MD
Resistant fibrotic calcified plaque is a major limitation in treating peripheral arterial disease. Percutaneous transluminal angioplasty balloon pressures of 8-16 atms are typically required in these lesions. Ultrasound has detected...
Resistant fibrotic calcified plaque is a major limitation in treating peripheral arterial disease. Percutaneous transluminal angioplasty balloon pressures of 8-16 atms are typically required in these lesions. Ultrasound has detected...
Resistant fibrotic calcified...
01/29/2013
Journal of Invasive Cardiology